Improvement in endothelial function in cardiovascular disease-Is arginase the target?

A Mahdi, O Kövamees, J Pernow - International journal of cardiology, 2020 - Elsevier
Endothelial dysfunction represents an early change in the vascular wall in areas prone to
atherosclerotic plaque formation and is present in association with several risk factors for …

The emerging role of arginase in endothelial dysfunction in diabetes

J Pernow, C Jung - Current vascular pharmacology, 2016 - ingentaconnect.com
Diabetes mellitus is a major risk factor for the development of cardiovascular disease due to
increased vascular inflammatory and oxidative stress favouring atherogenesis. Endothelial …

Arginase as a critical prooxidant mediator in the binomial endothelial dysfunction‐atherosclerosis

LA Rabelo, FO Ferreira, V Nunes-Souza… - Oxidative Medicine …, 2015 - Wiley Online Library
Arginase is a metalloenzyme which hydrolyzes L‐arginine to L‐ornithine and urea. Since its
discovery, in the early 1900s, this enzyme has gained increasing attention, as literature …

Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?

J Pernow, C Jung - Cardiovascular research, 2013 - academic.oup.com
Functional integrity of the vascular endothelium is of fundamental importance for normal
vascular function. A key factor regulating endothelial function is the bioavailability of nitric …

Endothelial arginase: a new target in atherosclerosis

Z Yang, XF Ming - Current hypertension reports, 2006 - Springer
Decreased endothelial nitric oxide (NO) bioavailability as it relates to endothelial dysfunction
plays an important role in various cardiovascular disorders, including atherosclerosis …

Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels

DE Berkowitz, R White, D Li, KM Minhas, A Cernetich… - Circulation, 2003 - Am Heart Assoc
Background—Although abnormal l-arginine NO signaling contributes to endothelial
dysfunction in the aging cardiovascular system, the biochemical mechanisms remain …

Oxidized low-density lipoprotein–dependent endothelial arginase II activation contributes to impaired nitric oxide signaling

S Ryoo, CA Lemmon, KG Soucy, G Gupta… - Circulation …, 2006 - Am Heart Assoc
Oxidized low-density lipoprotein (OxLDL) impairs NO signaling and endothelial function,
and contributes to the pathogenesis of atherosclerosis. Arginase reciprocally regulates NO …

[HTML][HTML] Development of novel arginase inhibitors for therapy of endothelial dysfunction

J Steppan, D Nyhan, DE Berkowitz - Frontiers in immunology, 2013 - frontiersin.org
Endothelial dysfunction and resulting vascular pathology have been identified as an early
hallmark of multiple diseases, including diabetes mellitus. One of the major contributors to …

Diabetes-induced vascular dysfunction involves arginase I

MJ Romero, JA Iddings, DH Platt… - American Journal …, 2012 - journals.physiology.org
Arginase can cause vascular dysfunction by competing with nitric oxide synthase for l-
arginine and by increasing cell proliferation and collagen formation, which promote vascular …

Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes mellitus

A Shemyakin, O Kövamees, A Rafnsson, F Böhm… - Circulation, 2012 - Am Heart Assoc
Background—Endothelial dysfunction plays an important role in the early development of
atherosclerosis and vascular complications in type 2 diabetes mellitus. Increased …